Discover
MNKD
MannKind Corporation
4.05
2 x 3.05
2 x 5.29
bid
ask
-
0.21
4.93%
2 @ 06:19 AM
4.00 -0.05 (1.23%)
| Ytd | -28.57% | |
| 1y | 13.13% |
4.05
day range
4.30
2.23
52 week range
6.51
| Open | 4.29 | Prev Close | 4.26 | Low | 4.05 | High | 4.30 | Mkt Cap | 1.25B |
| Vol | 2.72M | Avg Vol | 5.47M | EPS | -0.07 | P/E | N/A | Forward P/E | 21.04 |
| Beta | 1.11 | Short Ratio | 5.91 | Inst. Own | 59.28% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 3.42 | 200-d Avg | 4.47 | 1yr Est | 7.59 |
MNKD News
benzinga.com
MannKind Awarded Grant From Breakthrough T1D To Support Ongoing INHALE-1ST Clinical Study Evaluating
Collaboration underscores interest in inhaled insulin and strengthens bringing innovation and new op
benzinga.com
Reported Friday, MannKind's Afrezza Data At ADA Highlight Pediatric Safety, Gestational Diabetes Eff
Builds on recent FDA approval (May 29, 2026) of Afrezza for use in children and adolescents aged 6 a
benzinga.com
Jim Cramer Puts This Chip Stock In The 'Penalty Box,' Warns Occidental Could 'Go Down A Lot' If War
Cramer put Photronics in the penalty box due to poor results. He praised Woodward and warned against
benzinga.com
MannKind Announces Key Clinical Execution Milestones In The Development Of Nintedanib DPI For Idiopa
MannKind Corporation (NASDAQ:MNKD), a biopharmaceutical company focused on developing innovative, pa